 | • レポートコード：MRC2303H229 • 出版社/出版日：360iResearch / 2022年10月11日 • レポート形態：英語、PDF、231ページ • 納品方法：Eメール（受注後2-3日） • 産業分類：医療機器 |
| Single User（1名利用、印刷可） | ￥742,350 (USD4,949) | ▷ お問い合わせ |
| Enterprise License（企業利用、印刷可） | ￥1,492,350 (USD9,949) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 360iResearch社の当調査レポートでは、2021年に1,483.04百万ドルであった世界のTDM試薬キット市場規模が2022年に1,674.53百万ドルとなり、今後は年平均14.04％成長して2027年までに3,263.35百万ドルに達すると予測しています。当書は、TDM試薬キットの世界市場について調査し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、薬剤種類別（アミカシン、カルバマゼピン、ゲンタマイシン、ラモトリジン、NAPA）分析、ELISA種類別（抗体スクリーニング（定性的）、抗体スクリーニング（定量的））分析、疾患別（抗アレルギー＆喘息、抗がん剤、抗炎症薬、抗TNFα、チェックポイント阻害剤）分析、サンプル種類別（血漿、血清）分析、地域別（南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他）分析、競争状況、企業情報など、以下の構成でまとめております。なお、当書には、Aalto Scientific, Ltd.、Abbott Laboratories Inc.、ApDia Group、ARK Diagnostics, Inc.、Bio-Rad Laboratories, Inc.、bioMérieux SA、BioTeZ Berlin-Buch GmbH、Danaher Corporation、Eagle Biosciences, Inc.、Exagen Inc.、F. Hoffmann-La Rocheなどの企業情報が含まれています。 ・序論 ・調査方法 ・エグゼクティブサマリー ・市場概要 ・市場インサイト ・世界のTDM試薬キット市場規模：薬剤種類別 - アミカシンの市場規模 - カルバマゼピンの市場規模 - ゲンタマイシンの市場規模 - ラモトリジンの市場規模 - NAPAの市場規模 ・世界のTDM試薬キット市場規模：ELISA種類別 - 抗体スクリーニング（定性的）の市場規模 - 抗体スクリーニング（定量的）の市場規模 ・世界のTDM試薬キット市場規模：疾患別 - 抗アレルギー＆喘息における市場規模 - 抗がん剤における市場規模 - 抗炎症薬における市場規模 - 抗TNFαにおける市場規模 - チェックポイント阻害剤 ・世界のTDM試薬キット市場規模：サンプル種類別 - 血漿の市場規模 - 血清の市場規模 ・世界のTDM試薬キット市場規模：地域別 - 南北アメリカのTDM試薬キット市場規模 アメリカのTDM試薬キット市場規模 カナダのTDM試薬キット市場規模 ブラジルのTDM試薬キット市場規模 ... - アジア太平洋のTDM試薬キット市場規模 日本のTDM試薬キット市場規模 中国のTDM試薬キット市場規模 インドのTDM試薬キット市場規模 韓国のTDM試薬キット市場規模 台湾のTDM試薬キット市場規模 ... - ヨーロッパ/中東/アフリカのTDM試薬キット市場規模 イギリスのTDM試薬キット市場規模 ドイツのTDM試薬キット市場規模 フランスのTDM試薬キット市場規模 ロシアのTDM試薬キット市場規模 ... - その他地域のTDM試薬キット市場規模 ・競争状況 ・企業情報 |
The Global TDM Reagent Kit Market size was estimated at USD 1,483.04 million in 2021 and expected to reach USD 1,674.53 million in 2022, and is projected to grow at a CAGR 14.04% to reach USD 3,263.35 million by 2027.
Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.
Market Segmentation & Coverage:
This research report categorizes the TDM Reagent Kit to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Drug Type, the market was studied across Amikacin, Carbamazepine, Gentamicin, Lamotrigine, NAPA, Phenobarbital, Phenytoin, Procainamide, Teicoplanin, Theophylline, Tobramycin, and Vancomycin.
Based on Elisa Type, the market was studied across Antibody screening – Qualitative, Antibody screening – Quantitative, and Free drug.
Based on Indication, the market was studied across Anti-Allergy and Asthma, Anti-Cancer, Anti-Inflammatory, Anti-TNFα, Checkpoint Inhibitors, Immune Stimulation, Obesity, Osteoporosis, and Wet AMD.
Based on Mechanism, the market was studied across Calibrator, Control, and Reagent.
Based on Sample Type, the market was studied across Plasma and Serum.
Based on End-Users, the market was studied across Clinical & Diagnostic Centers and Hospitals.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for TDM Reagent Kit market considering the current update on the conflict and its global response.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the TDM Reagent Kit Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global TDM Reagent Kit Market, including Aalto Scientific, Ltd., Abbott Laboratories Inc., ApDia Group, ARK Diagnostics, Inc., Bio-Rad Laboratories, Inc., bioMérieux SA, BioTeZ Berlin-Buch GmbH, Danaher Corporation, Eagle Biosciences, Inc., Exagen Inc., F. Hoffmann-La Roche, Grifols S.A., Immundiagnostik AG, JASEM Laboratory Systems and Solutions A.S., Ortho-Clinical Diagnostics, R-Biopharm AG, Randox Laboratories Ltd., SEKISUI MEDICAL CO., LTD., Shimadzu Europa GmbH, Siemens Healthineers AG, The Merck Group, Theradiag SA, and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report answers questions such as:
1. What is the market size and forecast of the Global TDM Reagent Kit Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global TDM Reagent Kit Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global TDM Reagent Kit Market?
4. What is the competitive strategic window for opportunities in the Global TDM Reagent Kit Market?
5. What are the technology trends and regulatory frameworks in the Global TDM Reagent Kit Market?
6. What is the market share of the leading vendors in the Global TDM Reagent Kit Market?
7. What modes and strategic moves are considered suitable for entering the Global TDM Reagent Kit Market?
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Use of reagents for automated analyzers to measure blood concentrations of drugs
5.1.1.2. Demand for liquid-ready-to-use reagents for increased convenience
5.1.1.3. Growing prospect of TDM reagent kits with the growth of infectious diseases
5.1.2. Restraints
5.1.2.1. Limited penetration in clinical services
5.1.3. Opportunities
5.1.3.1. Growth in diagnostics & clinical laboratories worldwide
5.1.3.2. Increasing adoption in the treatment of autoimmune diseases
5.1.4. Challenges
5.1.4.1. Operational limitations with TDM tests
5.2. Cumulative Impact of COVID-19
6. TDM Reagent Kit Market, by Drug Type
6.1. Introduction
6.2. Amikacin
6.3. Carbamazepine
6.4. Gentamicin
6.5. Lamotrigine
6.6. NAPA
6.7. Phenobarbital
6.8. Phenytoin
6.9. Procainamide
6.10. Teicoplanin
6.11. Theophylline
6.12. Tobramycin
6.13. Vancomycin
7. TDM Reagent Kit Market, by Elisa Type
7.1. Introduction
7.2. Antibody screening – Qualitative
7.3. Antibody screening – Quantitative
7.4. Free drug
8. TDM Reagent Kit Market, by Indication
8.1. Introduction
8.2. Anti-Allergy and Asthma
8.3. Anti-Cancer
8.4. Anti-Inflammatory
8.5. Anti-TNFα
8.6. Checkpoint Inhibitors
8.7. Immune Stimulation
8.8. Obesity
8.9. Osteoporosis
8.10. Wet AMD
9. TDM Reagent Kit Market, by Mechanism
9.1. Introduction
9.2. Calibrator
9.3. Control
9.4. Reagent
10. TDM Reagent Kit Market, by Sample Type
10.1. Introduction
10.2. Plasma
10.3. Serum
11. TDM Reagent Kit Market, by End-Users
11.1. Introduction
11.2. Clinical & Diagnostic Centers
11.3. Hospitals
12. Americas TDM Reagent Kit Market
12.1. Introduction
12.2. Argentina
12.3. Brazil
12.4. Canada
12.5. Mexico
12.6. United States
13. Asia-Pacific TDM Reagent Kit Market
13.1. Introduction
13.2. Australia
13.3. China
13.4. India
13.5. Indonesia
13.6. Japan
13.7. Malaysia
13.8. Philippines
13.9. Singapore
13.10. South Korea
13.11. Taiwan
13.12. Thailand
13.13. Vietnam
14. Europe, Middle East & Africa TDM Reagent Kit Market
14.1. Introduction
14.2. Denmark
14.3. Egypt
14.4. Finland
14.5. France
14.6. Germany
14.7. Israel
14.8. Italy
14.9. Netherlands
14.10. Nigeria
14.11. Norway
14.12. Poland
14.13. Qatar
14.14. Russia
14.15. Saudi Arabia
14.16. South Africa
14.17. Spain
14.18. Sweden
14.19. Switzerland
14.20. Turkey
14.21. United Arab Emirates
14.22. United Kingdom
15. Competitive Landscape
15.1. FPNV Positioning Matrix
15.1.1. Quadrants
15.1.2. Business Strategy
15.1.3. Product Satisfaction
15.2. Market Ranking Analysis, By Key Player
15.3. Market Share Analysis, By Key Player
15.4. Competitive Scenario
15.4.1. Merger & Acquisition
15.4.2. Agreement, Collaboration, & Partnership
15.4.3. New Product Launch & Enhancement
15.4.4. Investment & Funding
15.4.5. Award, Recognition, & Expansion
16. Company Usability Profiles
16.1. Aalto Scientific, Ltd.
16.1.1. Business Overview
16.1.2. Key Executives
16.1.3. Product & Services
16.2. Abbott Laboratories Inc.
16.2.1. Business Overview
16.2.2. Key Executives
16.2.3. Product & Services
16.3. ApDia Group
16.3.1. Business Overview
16.3.2. Key Executives
16.3.3. Product & Services
16.4. ARK Diagnostics, Inc.
16.4.1. Business Overview
16.4.2. Key Executives
16.4.3. Product & Services
16.5. Bio-Rad Laboratories, Inc.
16.5.1. Business Overview
16.5.2. Key Executives
16.5.3. Product & Services
16.6. bioMérieux SA
16.6.1. Business Overview
16.6.2. Key Executives
16.6.3. Product & Services
16.7. BioTeZ Berlin-Buch GmbH
16.7.1. Business Overview
16.7.2. Key Executives
16.7.3. Product & Services
16.8. Danaher Corporation
16.8.1. Business Overview
16.8.2. Key Executives
16.8.3. Product & Services
16.9. Eagle Biosciences, Inc.
16.9.1. Business Overview
16.9.2. Key Executives
16.9.3. Product & Services
16.10. Exagen Inc.
16.10.1. Business Overview
16.10.2. Key Executives
16.10.3. Product & Services
16.11. F. Hoffmann-La Roche
16.11.1. Business Overview
16.11.2. Key Executives
16.11.3. Product & Services
16.12. Grifols S.A.
16.12.1. Business Overview
16.12.2. Key Executives
16.12.3. Product & Services
16.13. Immundiagnostik AG
16.13.1. Business Overview
16.13.2. Key Executives
16.13.3. Product & Services
16.14. JASEM Laboratory Systems and Solutions A.S.
16.14.1. Business Overview
16.14.2. Key Executives
16.14.3. Product & Services
16.15. Ortho-Clinical Diagnostics
16.15.1. Business Overview
16.15.2. Key Executives
16.15.3. Product & Services
16.16. R-Biopharm AG
16.16.1. Business Overview
16.16.2. Key Executives
16.16.3. Product & Services
16.17. Randox Laboratories Ltd.
16.17.1. Business Overview
16.17.2. Key Executives
16.17.3. Product & Services
16.18. SEKISUI MEDICAL CO., LTD.
16.18.1. Business Overview
16.18.2. Key Executives
16.18.3. Product & Services
16.19. Shimadzu Europa GmbH
16.19.1. Business Overview
16.19.2. Key Executives
16.19.3. Product & Services
16.20. Siemens Healthineers AG
16.20.1. Business Overview
16.20.2. Key Executives
16.20.3. Product & Services
16.21. The Merck Group
16.21.1. Business Overview
16.21.2. Key Executives
16.21.3. Product & Services
16.22. Theradiag SA
16.22.1. Business Overview
16.22.2. Key Executives
16.22.3. Product & Services
16.23. Thermo Fisher Scientific, Inc.
16.23.1. Business Overview
16.23.2. Key Executives
16.23.3. Product & Services
17. Appendix
17.1. Discussion Guide
17.2. License & Pricing